CDC Group invests $57 million in Cholamandalam

CDC Group invests $57 million in Cholamandalam

Rishikesh Gaikwad
/ Categories: Trending

CDC Group Plc, the UK government’s development finance institution, has invested Rs 400 crore in Cholamandalam Investment and Finance Company Ltd through 10-year masala bonds.

Masala bonds are those bonds, which are issued outside India but denominated in Indian rupees, rather than the local currency.

The non-banking financial company issued its maiden masala bonds or unsecured, subordinated, rupee-denominated bonds to raise Rs 400 crore Tier-II debts from the CDC group.

Cholamandalam said in a statement that the bond issue may be listed on London Stock Exchange or any other international stock exchanges in the future.

In December last year, the financial services firm’s board approved the issuance of equity shares worth Rs 1,000 crore through Qualified Institutional Placement (QIP), in one or more tranches.

In May, the investment arm of World Bank - International Finance Corporation, had led a $222 million debt investment round in Cholamandalam, marking its third investment in the NBFC.

Incorporated in 1978, Cholamandalam offers vehicle finance constituting 74 per cent of its portfolio, 21 per cent business loans including loan-against-property to MSME sector loans and home loans as on September end 2019. It has more than 1,000 branches across India, with a diversified loan portfolio spanning 1.2 million customers.

The firm caters to small and medium road transport operators for new and used commercial vehicles with over 50 per cent of the portfolio in low-income states.

In India, CDC has committed to more than $1.7 billion to businesses with a historical ticket size of its equity investment in Indian companies ranging from $10 million to as much as $150 million in India Infoline Finance Ltd.

CDC has backed more than 50 private equity and venture capital funds that invest in India, since it began focussing on the country in 2004.

With net assets of £5.8 billion (Rs 53,825 crore), CDC supports businesses that can make goods and services more affordable and accessible to the needy people in Africa and Asia.

Last month, the CDC Group had invested Rs 215 crore ($30.3 million) in debt in Dr Agarwal’s Health Care Ltd.

In the same month, it also made an equity investment of $36 million (Rs 255.36 crore) in Warburg Pincus-backed logistics firm-Ecom Express Pvt Ltd.

In the logistics segment, CDC had invested $25 million in Pristine Logistics and Infraprojects Pvt Ltd, which builds and operates rail freight terminals, in 2015. Its overall bet on Pristine is way higher at $200 million, through a combination of equity and debt investment. CDC exited the company in 2018.

Last year, it contributed Rs 100 crore of the Rs 145 crore raised by Gurugram-based fintech startup-Indifi Technologies Pvt Ltd and also, bet on an Indian dairy startup.

Previous Article Index trend and stocks in action January 13, 2020
Next Article Sachin Bansal's Navi buys insurer, seeks bank licence
Rate this article:
5.0

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR